Iterum Therapeutics Plc logo

Iterum Therapeutics Plc share price today

(ITRM)

Iterum Therapeutics Plc share price is $1.98 & ₹169.90 as on 7 Jan 2025, 2.30 'hrs' IST

$1.98

0.08

(4.21%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Iterum Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Iterum Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iterum Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Iterum Therapeutics Plc share price movements

  • Today's Low: $1.95
    Today's High: $2.08

    Day's Volatility :6.25%

  • 52 Weeks Low: $0.81
    52 Weeks High: $3.02

    52 Weeks Volatility :73.25%

Iterum Therapeutics Plc Returns

PeriodIterum Therapeutics PlcIndex (Russel 2000)
3 Months
98.35%
0.0%
6 Months
40.74%
0.0%
1 Year
-8.21%
0.0%
3 Years
-68.01%
-19.8%

Iterum Therapeutics Plc Key Statistics

in dollars & INR

Previous Close
$1.9
Open
$1.98
Today's High
$2.08
Today's Low
$1.95
Market Capitalization
$48.7M
Today's Volume
$476.2K
52 Week High
$3.02
52 Week Low
$0.808
Revenue TTM
$0.0
EBITDA
$-37.4M
Earnings Per Share (EPS)
$-1.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-555.68%

How to invest in Iterum Therapeutics Plc from India?

It is very easy for Indian residents to invest directly in Iterum Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iterum Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iterum Therapeutics Plc or ITRM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iterum Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iterum Therapeutics Plc shares which would translate to 0.433 fractional shares of Iterum Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iterum Therapeutics Plc, in just a few clicks!

Returns in Iterum Therapeutics Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iterum Therapeutics Plc investment value today

Current value as on today

₹98,875

Returns

₹1,125

(-1.13%)

Returns from Iterum Therapeutics Plc Stock

₹4,348 (-4.35%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Iterum Therapeutics Plc

-10%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Iterum Therapeutics Plc on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -10% less investors are searching Iterum Therapeutics Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Iterum Therapeutics Plc

  • Armistice Capital, LLC

    4.87%

  • New Leaf Venture Partners, L.L.C.

    1.25%

  • Apollon Financial LLC

    0.82%

  • Alpine Partners VI, LLC

    0.24%

  • XTX Topco Ltd

    0.12%

  • TWO SIGMA SECURITIES, LLC

    0.05%

Analyst Recommendation on Iterum Therapeutics Plc

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Iterum Therapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
6
Hold
1
1
2
Sell
0
0
0

Analyst Forecast on Iterum Therapeutics Plc

What analysts predicted

Upside of 278.79%

Current:

$1.98

Target:

$7.50

Insights on Iterum Therapeutics Plc

  • Price Movement

    In the last 1 month, ITRM stock has moved down by -29.6%
  • ITRM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 29.2%
  • ITRM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 124.3%

Iterum Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Iterum Therapeutics Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iterum Therapeutics Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Iterum Therapeutics Plc
-34.71%
40.74%
-8.21%
-68.01%
-97.05%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Iterum Therapeutics Plc
NA
NA
NA
-1.03
-5.56
-0.73
NA
-0.47
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Iterum Therapeutics Plc
Buy
$48.7M
-97.05%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Iterum Therapeutics Plc

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com.
Organization
Iterum Therapeutics Plc
Employees
14
CEO
Mr. Corey N. Fishman
Industry
Health Technology

Management People of Iterum Therapeutics Plc

NameTitle
Mr. Corey N. Fishman
President, CEO & Director
Ms. Judith M. Matthews
Chief Financial Officer
Dr. Michael W. Dunne M.D.
Strategic Advisor & Director
Mr. Tom Loughman Ph.D.
Senior Vice President of Technical Operations
Ms. Louise Barrett
Senior Vice President of Legal Affairs & Secretary
Dr. Steven I. Aronin M.D.
Senior VP & Head of Clinical Development

Important FAQs about investing in Iterum Therapeutics Plc from India :

What is Iterum Therapeutics Plc share price today?

Iterum Therapeutics Plc share price today stands at $1.98, Open: $1.98 ; Previous Close: $1.90 ; High: $2.08 ; Low: $1.95 ; 52 Week High: $3.02 ; 52 Week Low: $0.81. The stock opens at $1.98, after a previous close of $1.90. The stock reached a daily high of $2.08 and a low of $1.95, with a 52-week high of $3.02 and a 52-week low of $0.81.

Can Indians buy Iterum Therapeutics Plc shares?

Yes, Indians can invest in the Iterum Therapeutics Plc (ITRM) from India.

With INDmoney, you can buy Iterum Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Iterum Therapeutics Plc at zero transaction cost.

How can I buy Iterum Therapeutics Plc shares from India?

It is very easy to buy Iterum Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iterum Therapeutics Plc be purchased?

Yes, you can buy fractional shares of Iterum Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Iterum Therapeutics Plc stocks?

To start investing in Iterum Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Iterum Therapeutics Plc

Today’s highest price of Iterum Therapeutics Plc (ITRM) is $2.08.

Today’s lowest price of Iterum Therapeutics Plc (ITRM) is $1.95.

What is today's market capitalisation of Iterum Therapeutics Plc

Today's market capitalisation of Iterum Therapeutics Plc ITRM is 48.7M

What is the 52 Week High and Low Range of Iterum Therapeutics Plc

  • 52 Week High

    $3.02

  • 52 Week Low

    $0.81

What are the historical returns of Iterum Therapeutics Plc?

  • 1 Month Returns

    -34.71%

  • 3 Months Returns

    40.74%

  • 1 Year Returns

    -8.21%

  • 5 Years Returns

    -97.05%

Who is the Chief Executive Officer (CEO) of Iterum Therapeutics Plc

Mr. Corey N. Fishman is the current Chief Executive Officer (CEO) of Iterum Therapeutics Plc.